2
Announcements
Trials
Browse
Landscape
Phase
Phase 1/2
1
Status
Unknown
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Conditions
Prostatic Neoplasms
58
Breast Neoplasms
14
Polycystic Ovary Syndrome
9
Infertility
7
Ovarian Hyperstimulation Syndrome
3
Neoplasms
3
Neoplasm Metastasis
3
Lymphoma
3
Sarcoma, Ewing
2
Sarcoma
2
Prostate Adenocarcinoma
2
Osteosarcoma
2
Uterine Anomalies
1
The Neoadjuvant Therapy
1
Sleep Wake Disorders
1
Salpingitis
1
Salivary Gland Neoplasms
1
Primary Ovarian Insufficiency
1
Pregnancy, Ectopic
1
Neoadjuvant Therapy \ High Risk Prostate Cancer \ Docetaxel
1
Myofibroma
1
Metabolic Syndrome
1
Leiomyoma
1
Infertility, Female
1
Hypogonadism
1
Hodgkin Disease
1
Hematopoietic and Lymphatic System Neoplasm
1
Helping Behavior
1
Fatty Liver
1
Fatigue
1
Interventions
follitropin alfa
1
Urofollitropin
1
Triptorelin Pamoate
1
Injections
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Helping Behavior
×
Triptorelin Pamoate
×
Clear all
NCT04616729
2023-05-18
Depo-Trigger
Universitair Ziekenhuis Brussel
Phase 1/2
Unknown
30 enrolled